{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:19:05Z","timestamp":1787624345055,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00210-026-05455-x","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:01:42Z","timestamp":1780012902000},"page":"17825-17837","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pristimerin enhances erastin-induced ferroptosis in AML cells via the ATF3\/SLC7A11 axis"],"prefix":"10.1007","volume":"399","author":[{"given":"Shan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beizhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"5455_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113950","volume":"156","author":"M Al-Tamimi","year":"2022","unstructured":"Al-Tamimi M, Khan AQ, Anver R et al (2022) Pristimerin mediated anticancer effects and sensitization of human skin cancer cells through modulation of MAPK signaling pathways. Biomed Pharmacother 156:113950. https:\/\/doi.org\/10.1016\/j.biopha.2022.113950","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"5455_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/tox.23857","volume":"39","author":"R Bi","year":"2024","unstructured":"Bi R, Hu R, Jiang L et al (2024) Butyrate enhances erastin-induced ferroptosis of lung cancer cells via modulating the ATF3 \/ SLC7A11 pathway. Environ Toxicol 39(2):529\u2013538. https:\/\/doi.org\/10.1002\/tox.23857","journal-title":"Environ Toxicol"},{"key":"5455_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.671548","volume":"11","author":"RZ Chen","year":"2021","unstructured":"Chen RZ, Yang F, Zhang M, Sun ZG, Zhang N (2021) Cellular and molecular mechanisms of pristimerin in cancer therapy: recent advances. Front Oncol 11:671548. https:\/\/doi.org\/10.3389\/fonc.2021.671548","journal-title":"Front Oncol"},{"issue":"1","key":"5455_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","volume":"9","author":"X Chu","year":"2024","unstructured":"Chu X, Tian W, Ning J et al (2024) Cancer stem cells: advances in knowledge and implications for cancer therapy. Signal Transduct Target Ther 9(1):170. https:\/\/doi.org\/10.1038\/s41392-024-01851-y","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"5455_CR5","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.3892\/ijo.2014.2325","volume":"44","author":"D Deeb","year":"2014","unstructured":"Deeb D, Gao X, Liu YB, Pindolia K, Gautam SC (2014) Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt\/NF-\u03baB\/mTOR signaling proteins and anti-apoptotic Bcl-2. Int J Oncol 44(5):1707\u20131715. https:\/\/doi.org\/10.3892\/ijo.2014.2325","journal-title":"Int J Oncol"},{"issue":"9","key":"5455_CR6","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1182\/blood.2019001982","volume":"136","author":"S DeWolf","year":"2020","unstructured":"DeWolf S, Tallman MS (2020) How I treat relapsed or refractory AML. Blood 136(9):1023\u20131032. https:\/\/doi.org\/10.1182\/blood.2019001982","journal-title":"Blood"},{"issue":"2","key":"5455_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1182\/blood.2019001239","volume":"135","author":"CD DiNardo","year":"2020","unstructured":"DiNardo CD, Wei AH (2020) How I treat acute myeloid leukemia in the era of new drugs. Blood 135(2):85\u201396. https:\/\/doi.org\/10.1182\/blood.2019001239","journal-title":"Blood"},{"key":"5455_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fitote.2015.08.006","volume":"106","author":"C Dong","year":"2015","unstructured":"Dong C, Xu C, Liu H, Xu S, Gao Y, Peng J (2015) Absorption and metabolism characteristics of pristimerin as determined by a sensitive and reliable LC\u2013MS\/MS method. Fitoterapia 106:62\u201367. https:\/\/doi.org\/10.1016\/j.fitote.2015.08.006","journal-title":"Fitoterapia"},{"issue":"1","key":"5455_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12967-021-03042-7","volume":"19","author":"L Feng","year":"2021","unstructured":"Feng L, Zhao K, Sun L et al (2021) SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis. J Transl Med 19(1):367. https:\/\/doi.org\/10.1186\/s12967-021-03042-7","journal-title":"J Transl Med"},{"issue":"5","key":"5455_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S1875-5364(25)60865-X","volume":"23","author":"M Feng","year":"2025","unstructured":"Feng M, Zhang A, Wu J et al (2025) Pristimerin induces Noxa-dependent apoptosis by activating the FoxO3a pathway in esophageal squamous cell carcinoma. Chin J Nat Med 23(5):585\u2013592. https:\/\/doi.org\/10.1016\/S1875-5364(25)60865-X","journal-title":"Chin J Nat Med"},{"issue":"5","key":"5455_CR11","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.tips.2024.03.005","volume":"45","author":"M Forsberg","year":"2024","unstructured":"Forsberg M, Konopleva M (2024) AML treatment: conventional chemotherapy and emerging novel agents. Trends Pharmacol Sci 45(5):430\u2013448. https:\/\/doi.org\/10.1016\/j.tips.2024.03.005","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"5455_CR12","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/ajh.25162","volume":"93","author":"C Ganzel","year":"2018","unstructured":"Ganzel C, Sun Z, Cripe LD et al (2018) Very poor long-term survival in past and more recent studies for relapsed AML patients: the ECOG-ACRIN experience. Am J Hematol 93(8):1074\u20131081. https:\/\/doi.org\/10.1002\/ajh.25162","journal-title":"Am J Hematol"},{"issue":"6","key":"5455_CR13","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1158\/0008-5472.CAN-20-3477","volume":"81","author":"A Ghoochani","year":"2021","unstructured":"Ghoochani A, Hsu EC, Aslan M et al (2021) Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer. Cancer Res 81(6):1583\u20131594. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-3477","journal-title":"Cancer Res"},{"issue":"2","key":"5455_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmr.2024.100030","volume":"77","author":"A Glaviano","year":"2025","unstructured":"Glaviano A, Singh SK, Lee EHC et al (2025) Cell cycle dysregulation in cancer. Pharmacol Rev 77(2):100030. https:\/\/doi.org\/10.1016\/j.pharmr.2024.100030","journal-title":"Pharmacol Rev"},{"issue":"4","key":"5455_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266\u2013282. https:\/\/doi.org\/10.1038\/s41580-020-00324-8","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"5455_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40880-018-0288-x","volume":"38","author":"P Koppula","year":"2018","unstructured":"Koppula P, Zhang Y, Zhuang L, Gan B (2018) Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun 38(1):12. https:\/\/doi.org\/10.1186\/s40880-018-0288-x","journal-title":"Cancer Commun"},{"issue":"8","key":"5455_CR17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B (2021) Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12(8):599\u2013620. https:\/\/doi.org\/10.1007\/s13238-020-00789-5","journal-title":"Protein Cell"},{"issue":"11","key":"5455_CR18","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1016\/j.ymthe.2020.08.021","volume":"28","author":"J Liu","year":"2020","unstructured":"Liu J, Xia X, Huang P (2020) xCT: a critical molecule that links cancer metabolism to redox signaling. Mol Ther 28(11):2358\u20132366. https:\/\/doi.org\/10.1016\/j.ymthe.2020.08.021","journal-title":"Mol Ther"},{"issue":"10","key":"5455_CR19","doi-asserted-by":"publisher","first-page":"2413174","DOI":"10.1002\/advs.202413174","volume":"12","author":"Q Liu","year":"2025","unstructured":"Liu Q, Fan Q, Chen J et al (2025) Pristimerin promotes ubiquitination of HSPA8 and activates the VAV1\/ERK pathway to suppress TNBC proliferation. Adv Sci 12(10):2413174. https:\/\/doi.org\/10.1002\/advs.202413174","journal-title":"Adv Sci"},{"key":"5455_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156139","volume":"135","author":"C Lu","year":"2024","unstructured":"Lu C, Zhang Z, Fan Y, Wang X, Qian J, Bian Z (2024) Shikonin induces ferroptosis in osteosarcomas through the mitochondrial ROS-regulated HIF-1\u03b1\/HO-1 axis. Phytomedicine 135:156139. https:\/\/doi.org\/10.1016\/j.phymed.2024.156139","journal-title":"Phytomedicine"},{"issue":"1","key":"5455_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cell.2018.02.014","volume":"173","author":"TMA Mohamed","year":"2018","unstructured":"Mohamed TMA, Ang YS, Radzinsky E et al (2018) Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration. Cell 173(1):104\u2013116.e12. https:\/\/doi.org\/10.1016\/j.cell.2018.02.014","journal-title":"Cell"},{"key":"5455_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216645","volume":"585","author":"D Shin","year":"2024","unstructured":"Shin D, Lee J, Roh JL (2024) Pioneering the future of cancer therapy: deciphering the p53-ferroptosis nexus for precision medicine. Cancer Lett 585:216645. https:\/\/doi.org\/10.1016\/j.canlet.2024.216645","journal-title":"Cancer Lett"},{"key":"5455_CR23","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.2147\/DDDT.S460093","volume":"18","author":"J Sun","year":"2024","unstructured":"Sun J, Tian Z, Wu J et al (2024) Pristimerin exerts pharmacological effects through multiple signaling pathways: a comprehensive review. Drug Des Devel Ther 18:1673\u20131694. https:\/\/doi.org\/10.2147\/DDDT.S460093","journal-title":"Drug Des Devel Ther"},{"key":"5455_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semcancer.2014.07.001","volume":"31","author":"E Vlashi","year":"2015","unstructured":"Vlashi E, Pajonk F (2015) Cancer stem cells, cancer cell plasticity and radiation therapy. Semin Cancer Biol 31:28\u201335. https:\/\/doi.org\/10.1016\/j.semcancer.2014.07.001","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"5455_CR25","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","volume":"27","author":"L Wang","year":"2020","unstructured":"Wang L, Liu Y, Du T et al (2020) ATF3 promotes erastin-induced ferroptosis by suppressing system xc. Cell Death Differ 27(2):662\u2013675. https:\/\/doi.org\/10.1038\/s41418-019-0380-z","journal-title":"Cell Death Differ"},{"key":"5455_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.bbi.2023.05.008","volume":"111","author":"X Wang","year":"2023","unstructured":"Wang X, Lin C, Jin S, Wang Y, Peng Y, Wang X (2023) Cannabidiol alleviates neuroinflammation and attenuates neuropathic pain via targeting FKBP5. Brain Behav Immun 111:365\u2013375. https:\/\/doi.org\/10.1016\/j.bbi.2023.05.008","journal-title":"Brain Behav Immun"},{"issue":"5","key":"5455_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189147","volume":"1879","author":"Z Wang","year":"2024","unstructured":"Wang Z, Ren M, Liu W, Wu J, Tang P (2024) Role of cell division cycle-associated proteins in regulating cell cycle and promoting tumor progression. Biochim Biophys Acta Rev Cancer 1879(5):189147. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189147","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"7","key":"5455_CR28","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41422-022-00642-w","volume":"32","author":"R Yan","year":"2022","unstructured":"Yan R, Xie E, Li Y et al (2022) The structure of erastin-bound xCT\u20134F2hc complex reveals molecular mechanisms underlying erastin-induced ferroptosis. Cell Res 32(7):687\u2013690. https:\/\/doi.org\/10.1038\/s41422-022-00642-w","journal-title":"Cell Res"},{"issue":"1","key":"5455_CR29","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1038\/s41467-023-39401-9","volume":"14","author":"Y Yan","year":"2023","unstructured":"Yan Y, Teng H, Hang Q et al (2023) SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells. Nat Commun 14(1):3673. https:\/\/doi.org\/10.1038\/s41467-023-39401-9","journal-title":"Nat Commun"},{"issue":"1","key":"5455_CR30","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13046-021-02012-7","volume":"40","author":"J Yang","year":"2021","unstructured":"Yang J, Zhou Y, Xie S et al (2021) Metformin induces ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer. J Exp Clin Cancer Res 40(1):206. https:\/\/doi.org\/10.1186\/s13046-021-02012-7","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"5455_CR31","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41419-022-04971-x","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Ma Y, Li Q et al (2022) STAT6 inhibits ferroptosis and alleviates acute lung injury via regulating P53\/SLC7A11 pathway. Cell Death Dis 13(6):530. https:\/\/doi.org\/10.1038\/s41419-022-04971-x","journal-title":"Cell Death Dis"},{"issue":"8","key":"5455_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112945","volume":"42","author":"Z Yang","year":"2023","unstructured":"Yang Z, Su W, Wei X et al (2023) HIF-1\u03b1 drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1. Cell Rep 42(8):112945. https:\/\/doi.org\/10.1016\/j.celrep.2023.112945","journal-title":"Cell Rep"},{"issue":"3","key":"5455_CR33","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.apsb.2025.02.003","volume":"15","author":"W Ye","year":"2025","unstructured":"Ye W, Yang P, Jin M et al (2025) Dihydromyricetin mitigates abdominal aortic aneurysm via transcriptional and post-transcriptional regulation of heme oxygenase-1 in vascular smooth muscle cells. Acta Pharm Sin B 15(3):1514\u20131534. https:\/\/doi.org\/10.1016\/j.apsb.2025.02.003","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"5455_CR34","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1042\/BST20120092","volume":"40","author":"MK Yoon","year":"2012","unstructured":"Yoon MK, Mitrea DM, Ou L, Kriwacki RW (2012) Cell cycle regulation by the intrinsically disordered proteins p21 and p27. Biochem Soc Trans 40(5):981\u2013988. https:\/\/doi.org\/10.1042\/BST20120092","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"5455_CR35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.canlet.2016.01.055","volume":"374","author":"H Zhao","year":"2016","unstructured":"Zhao H, Wang C, Lu B et al (2016) Pristimerin triggers AIF-dependent programmed necrosis in glioma cells via activation of JNK. Cancer Lett 374(1):136\u2013148. https:\/\/doi.org\/10.1016\/j.canlet.2016.01.055","journal-title":"Cancer Lett"},{"key":"5455_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153399","volume":"80","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Bi Y, Guo J et al (2021) Effect of pristimerin on apoptosis through activation of ROS\/ endoplasmic reticulum (ER) stress-mediated Noxa in colorectal cancer. Phytomedicine 80:153399. https:\/\/doi.org\/10.1016\/j.phymed.2020.153399","journal-title":"Phytomedicine"},{"key":"5455_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.semcancer.2020.11.010","volume":"83","author":"X Zhao","year":"2022","unstructured":"Zhao X, Liu H-q, Wang L-n, Yang L, Liu X-l (2022) Current and emerging molecular and epigenetic disease entities in acute myeloid leukemia and a critical assessment of their therapeutic modalities. Semin Cancer Biol 83:121\u2013135. https:\/\/doi.org\/10.1016\/j.semcancer.2020.11.010","journal-title":"Semin Cancer Biol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05455-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05455-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05455-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:24:06Z","timestamp":1787621046000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05455-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5455"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05455-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}